☰

Rakesh K. Pathak, Ph.D - Publications

Affiliations: 
2017- Chemistry IISER Berhampur 
Area:
Nanomedicine, Bio-inorganic chemistry, Drug delivery, Cisplatin based prodrugs
Website:
https://www.rakeshpathaklab.com/
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Banerjee A, Bajaj G, Singhal NK, Pathak RK. Synthetically Tunable Suprahybrid Nanoparticle Platform for the Efficacious Delivery of Therapeutics. Acs Applied Materials & Interfaces. PMID 37927061 DOI: 10.1021/acsami.3c11626  0.749
2019 Nair S, Strohecker AM, Persaud AK, Bissa B, Muruganandan S, McElroy C, Pathak R, Williams M, Raj R, Kaddoumi A, Sparreboom A, Beedle AM, Govindarajan R. Adult stem cell deficits drive Slc29a3 disorders in mice. Nature Communications. 10: 2943. PMID 31270333 DOI: 10.1038/S41467-019-10925-3  0.445
2018 Pathak RK, Basu U, Ahmad A, Sarkar S, Kumar A, Surnar B, Ansari S, Wilczek K, Ivan ME, Marples B, Kolishetti N, Dhar S. A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation. Biomaterials. 187: 117-129. PMID 30336364 DOI: 10.1016/J.Biomaterials.2018.08.062  0.748
2017 Mody HR, Hung SW, Naidu K, Lee H, Gilbert CA, Hoang TT, Pathak RK, Manoharan R, Muruganandan S, Govindarajan R. SET contributes to the epithelial-mesenchymal transition of pancreatic cancer. Oncotarget. 8: 67966-67979. PMID 28978088 DOI: 10.18632/Oncotarget.19067  0.48
2017 Mody H, Hung SW, Pathak R, Griffin J, Cruz-Monserrate Z, Govindarajan R. miR-202 Diminishes TGFbeta Receptors and Attenuates TGFbeta1-induced EMT in Pancreatic Cancer. Molecular Cancer Research : McR. PMID 28373289 DOI: 10.1158/1541-7786.Mcr-16-0327  0.442
2017 Pathak RK, Wen R, Kolishetti N, Dhar S. A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer. Molecular Cancer Therapeutics. PMID 28148716 DOI: 10.1158/1535-7163.Mct-16-0445  0.695
2016 Basu U, Banik B, Wen R, Pathak RK, Dhar S. The Platin-X series: activation, targeting, and delivery. Dalton Transactions (Cambridge, England : 2003). PMID 27493131 DOI: 10.1039/C6Dt01738J  0.754
2016 Pathak RK, Dhar S. Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug. Chemistry (Weinheim An Der Bergstrasse, Germany). 22: 3029-36. PMID 26807548 DOI: 10.1002/Chem.201503866  0.643
2016 Wen R, Banik B, Pathak RK, Kumar A, Kolishetti N, Dhar S. Nanotechnology inspired tools for mitochondrial dysfunction related diseases. Advanced Drug Delivery Reviews. PMID 26776231 DOI: 10.1016/J.Addr.2015.12.024  0.777
2016 Mummidivarapu VVS, Pathak RK, Rao CP. Structure of a di-zinc complex of a bis-calix[4]arene conjugate and its sensing of cysteine among the amino acids Supramolecular Chemistry. 1-8. DOI: 10.1080/10610278.2015.1129406  0.59
2016 Pathak RK, Dhar S. Combined Chemo-Anti-Inflammatory Prodrugs and Nanoparticles Synlett. 27: 1607-1612. DOI: 10.1055/S-0035-1561440  0.689
2015 Kalathil AA, Kumar A, Banik B, Ruiter TA, Pathak RK, Dhar S. New formulation of old aspirin for better delivery. Chemical Communications (Cambridge, England). PMID 26503669 DOI: 10.1039/C5Cc07316B  0.724
2015 Feldhaeusser B, Platt SR, Marrache S, Kolishetti N, Pathak RK, Montgomery DJ, Reno LR, Howerth E, Dhar S. Evaluation of nanoparticle delivered cisplatin in beagles. Nanoscale. 7: 13822-30. PMID 26234400 DOI: 10.1039/C5Nr03447G  0.769
2015 Pathak RK, Dhar S. A Nanoparticle Cocktail: Temporal Release of Predefined Drug Combinations. Journal of the American Chemical Society. PMID 26086212 DOI: 10.1021/Jacs.5B03078  0.671
2015 Marrache S, Pathak RK, Dhar S. Formulation and optimization of mitochondria-targeted polymeric nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 1265: 103-12. PMID 25634270 DOI: 10.1007/978-1-4939-2288-8_8  0.777
2015 Pathak RK, Kolishetti N, Dhar S. Targeted nanoparticles in mitochondrial medicine. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 7: 315-29. PMID 25348382 DOI: 10.1002/Wnan.1305  0.685
2014 Marrache S, Pathak RK, Dhar S. Detouring of cisplatin to access mitochondrial genome for overcoming resistance. Proceedings of the National Academy of Sciences of the United States of America. 111: 10444-9. PMID 25002500 DOI: 10.1073/Pnas.1405244111  0.785
2014 Pathak RK, McNitt CD, Popik VV, Dhar S. Copper-free click-chemistry platform to functionalize cisplatin prodrugs. Chemistry (Weinheim An Der Bergstrasse, Germany). 20: 6861-5. PMID 24756923 DOI: 10.1002/Chem.201402573  0.641
2014 Pathak RK, Marrache S, Harn DA, Dhar S. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. Acs Chemical Biology. 9: 1178-87. PMID 24617941 DOI: 10.1021/Cb400944Y  0.772
2014 Pathak RK, Marrache S, Choi JH, Berding TB, Dhar S. The prodrug platin-A: simultaneous release of cisplatin and aspirin. Angewandte Chemie (International Ed. in English). 53: 1963-7. PMID 24453035 DOI: 10.1002/Anie.201308899  0.773
2014 Mummidivarapu VVS, Pathak RK, Hinge VK, Dessingou J, Rao CP. A fluorescent di-zinc(II) complex of bis-calix[4]arene conjugate as chemosensing-ensemble for the selective recognition of ATP Supramolecular Chemistry. 26: 538-546. DOI: 10.6084/M9.Figshare.963304  0.539
2013 Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. Nanocarriers for tracking and treating diseases. Current Medicinal Chemistry. 20: 3500-14. PMID 23834187 DOI: 10.2174/0929867311320280007  0.787
2013 Pathak RK, Dessingou J, Hinge VK, Thawari AG, Basu SK, Rao CP. Quinoline driven fluorescence turn on 1,3-bis-calix[4]arene conjugate-based receptor to discriminate Fe3+ from Fe2+. Analytical Chemistry. 85: 3707-14. PMID 23441956 DOI: 10.1021/Ac400059W  0.515
2013 Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. Nanocarriers for tracking and treating diseases Current Medicinal Chemistry. 20: 3500-3514. DOI: 10.2174/0929867311320280007  0.743
2012 Pathak RK, Dessingou J, Rao CP. Multiple sensor array of Mn2+, Fe2+, Co2+, Ni2+, Cu2+, and Zn2+ complexes of a triazole linked imino-phenol based calix[4]arene conjugate for the selective recognition of Asp, Glu, Cys, and His. Analytical Chemistry. 84: 8294-300. PMID 22978667 DOI: 10.1021/Ac301821C  0.524
2012 Pathak RK, Hinge VK, Mondal P, Rao CP. Ratiometric fluorescence off-on-off sensor for Cu2+ in aqueous buffer by a lower rim triazole linked benzimidazole conjugate of calix[4]arene. Dalton Transactions (Cambridge, England : 2003). 41: 10652-60. PMID 22836215 DOI: 10.1039/C2Dt30432E  0.527
2012 Pathak RK, Hinge VK, Mahesh K, Rai A, Panda D, Rao CP. Cd2+ complex of a triazole-based calix[4]arene conjugate as a selective fluorescent chemosensor for Cys. Analytical Chemistry. 84: 6907-13. PMID 22834792 DOI: 10.1021/Ac301492H  0.537
2012 Pathak RK, Tabbasum K, Rai A, Panda D, Rao CP. A Zn2+ specific triazole based calix[4]arene conjugate (L) as a fluorescence sensor for histidine and cysteine in HEPES buffer milieu. The Analyst. 137: 4069-75. PMID 22822479 DOI: 10.1039/C2An35740B  0.533
2012 Pathak RK, Tabbasum K, Rai A, Panda D, Rao CP. Pyrophosphate sensing by a fluorescent Zn2+ bound triazole linked imino-thiophenyl conjugate of calix[4]arene in HEPES buffer medium: spectroscopy, microscopy, and cellular studies. Analytical Chemistry. 84: 5117-23. PMID 22551314 DOI: 10.1021/Ac301009H  0.542
2012 Pathak RK, Hinge VK, Rai A, Panda D, Rao CP. Imino-phenolic-pyridyl conjugates of calix[4]arene (L1 and L2) as primary fluorescence switch-on sensors for Zn2+ in solution and in HeLa cells and the recognition of pyrophosphate and ATP by [ZnL2]. Inorganic Chemistry. 51: 4994-5005. PMID 22519733 DOI: 10.1021/Ic202426V  0.538
2011 Pathak RK, Tabbasum K, Hinge VK, Rao CP. Selective recognition of cysteine in its free and protein-bound states by the Zn2+ complex of a triazole-based calix[4]arene conjugate. Chemistry (Weinheim An Der Bergstrasse, Germany). 17: 13999-4003. PMID 22084051 DOI: 10.1002/Chem.201102791  0.533
2011 Pathak RK, Hinge VK, Mondal M, Rao CP. Triazole-linked-thiophene conjugate of calix[4]arene: its selective recognition of Zn2+ and as biomimetic model in supporting the events of the metal detoxification and oxidative stress involving metallothionein. The Journal of Organic Chemistry. 76: 10039-49. PMID 22053726 DOI: 10.1021/Jo201865X  0.541
2010 Pathak RK, Dikundwar AG, Row TN, Rao CP. A lower rim triazole linked calix[4]arene conjugate as a fluorescence switch on sensor for Zn2+ in blood serum milieu. Chemical Communications (Cambridge, England). 46: 4345-7. PMID 20461281 DOI: 10.1039/C0Cc00219D  0.524
2009 Pathak RK, Ibrahim SM, Rao CP. Selective recognition of Zn2+ by salicylaldimine appended triazole-linked di-derivatives of calix[4]arene by enhanced fluorescence emission in aqueous-organic solutions: role of terminal -CH2OH moietieefs in conjunction with the imine in recognition Tetrahedron Letters. 50: 2730-2734. DOI: 10.1016/J.Tetlet.2009.03.126  0.535
Show low-probability matches.